HUNTINGTON, NY – Huntington Hospital has recently begun using the Micra®Transcatheter Pacing System (TPS).
Pacemakers are beneficial for patients with slow heartbeats as the device increases the heart rate and improves blood circulation when the patients’ heart rate is inadequate. The Micra TPS is less than one-tenth the size of traditional pacemakers and cosmetically invisible, yet it provides the most advanced pacing technology available. It is implanted directly into the heart and does not require the use of wires ("leads") to deliver pacing therapy, thereby reducing potential sources of complications seen with conventional pacing systems.
Patients who require dialysis and therefore need their arm/shoulder region for treatment are among those who could be good candidates for this procedure. Since the device does not have leads, arm usage does not need to be restricted because the device is placed through the groin. By not having any wire leads, this lowers the infection risk.
The Micra TPS was initially implanted at Huntington Hospital as part of a clinical trial. The Micra study was just one of several cutting edge clinical trials that the cardiac services department at Huntington Hospital is participating in.